A Review of Medication Non-adherence in Chronic Diseases: Thin Line between Health, Harm and the Vital Role of Pharmacists
DOI:
https://doi.org/10.51412/psnnjp.2025.47Keywords:
Medication adherence, non-adherence, role of pharmacists, pharmacist intervention, chronic diseasesAbstract
Adherence to prescribed medication regimens is essential for the effective management of chronic conditions. Non-adherence to treatment plans undermine therapeutic effectiveness, increases healthcare costs and elevates the risk of complications. Non-adherence, however, is complex and often results from numerous interacting factors. Some of these factors may be related or unrelated to the individual. Adherence to medications comprises three interrelated stages: initiation, implementation and discontinuation. Patients who fail to initiate treatment and those who discontinue treatment prematurely often experience the worst clinical outcomes. Numerous studies on non-adherence have proposed models that help explain why patients fail to adhere to their medications. While there is a paucity of studies on the reasons patients prematurely stop taking their medications, existing research suggests that the decision is often based on a combination of social, environmental and personal factors including adverse drug reactions. In the management of chronic diseases, there is often a delicate balance between effective disease control and clinical deterioration, underscoring the thin line between health and harm. It is therefore important for healthcare professionals, researchers, and stakeholders to prioritize efforts aimed at promoting adherence in individuals who suffer from chronic diseases. Pharmacists, as accessible members of the healthcare team, have a significant role to play. Some of their responsibilities include effective patient education and counselling, medication therapy management, monitoring and followup, use of medication management tools, collaboration with other healthcare providers, telepharmacy, integration of digital health technologies and tools, simplifying treatment regimens and community outreach and advocacy. To effectively manage chronic conditions, medication adherence must be prioritized. Patients should be adequately educated on the significance of following their treatment regimen and the potential consequences of non-adherence. Individualized strategies that address patients' unique beliefs and barriers to adherence should also be adopted.
References
1. World Health Organization. Noncommunicable diseases [Internet]. 2023. [Accessed 2025 April 5]. Available from: https://www.who.int/newsroom/fact-sheets/detail/noncommunicablediseases
2. Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle income countries: A systematic scoping review. Heliyon, 2022: 8(6): e09716. doi : https://doi.org/10.1016/j.heliyon.2022.e09716
3. Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, Li H, Chin YH, Kong G, Anand VV et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol, 2024, zwae281. doi: https://doi.org/10.1093/eurjpc/zwae281
4. Schnorrerova P, Matalova P, Wawruch M. Medication Adherence and Intervention Strategies: Why Should We Care. Bratisl. Med. J., 2025: 126: 1196 - 1206. doi : https://doi.org/10.1007/s44411-025-00227-0
5. Gast A, Mathes T. Medication adherence influencing factors - an (updated) overview of systematic reviews. Syst Rev, 2019:8:112. doi: https://doi.org/10.1186/s13643-019-1014-8
6. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med, 2000:133(1):21-30. doi: https://doi.org/10.7326/0003-4819-133-1-200007040-00004
7. Parikh MA, Ramachandran S, Nsiah I, Campbell PJ, Castora-Binkley M, Karmakar T, et al. Estimating optimal thresholds for adherence to RASA medications among older adults with hypertension. J Manag Care Spec Pharm, 2025: 31(1): 25-30. doi:
https://doi.org/10.18553/jmcp.2025.31.1.25
8. Lim MT, Rahman NA, Teh XR, Chan CL, Thevendran S, Hamdi NA et al. Optimal cut-off points for adherence measure among patients with type 2 diabetes in primary care clinics: a retrospective analysis. Ther Adv Chronic Dis. 2021: 17: 12: 2040622321990264. doi: https://doi.org/10.1177/2040622321990264
9. Religioni U, Barrios-Rodriquez R, Requena P, Borowska M, Ostrowski J. Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. Medicina, 2025: 61 (153): 2 - 12. doi: https://doi.org/10.3390/medicina61010153
10. Baumgartner PC, Haynes RB, Hersberger KE, Arnet I. A Systemic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes. Front Pharmacol, 2018:9:1290. doi: https://doi.org/10.3389/fphar.2018.01290
11. Kambira PFA, Noviani L, Hendrawan AMEL. Telepharmacy intervention: Can it impact medication adherence among patients with chronic disease? Pharm Educ, 2024: 24(2): 104 – 108. doi : https://doi.org/10.46542/pe.2024.242.104108
12. Osman Y, Ibrahim O, Mirghani Y. Pharmacist-Led Intervention on Medication Adherence and Its Impact on Health-Related Quality of Life and Preventing Acute Events Among Diabetic Patients: A Narrative Review. J Acute Care Resusc, 2024: 1(3): 64 – 69 . doi: https://doi.org/10.4103/jacresus.jacresus_13_24
13. Centers for Disease Control and Prevention. Pharmacy-Based Interventions to Improve Medication Adherence [Internet]. [Accessed 2025 Oct 18]. Available from: https://www.cdc.gov/cardiovascularresources/php/medication-adherence/index.html?utm_source=chatgpt.com
14. Bandiera C, Ricki NG, Mistry SK, Harris E, Harris M F, Aslani P. Th e Imp a c t o f interprofessional collaboration between pharmacists and community health workers on medication adherence: ASystematic Review. Int J Equity health, 2025:24(58):1–14. doi: https://doi.org/10.1186/s12939-025-02415-4
15. Khan R, Socha-Dietrich K. Investing in medication adherence improves health outcomes and health system efficiency: Adherence to medicines for diabetes, hypertension and hyperlipidaemia. OECD Health Work Pap, 2018: No. 105, OECD Publishing, Paris. doi: https://doi.org/10.1787/8178962c-en
16. Evans M, Engberg S, Faurby M, Fernandes JDDR, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: Asystemic literature review. Diabetes Obes. Metab., 2022: 24: 377 – 390. doi: https://doi.org/10.1111/dom.14603
17. Lee EKP, Poon P, Yip BHK, Bp Y, Zhu MT, Yu CP, Ngai ACH, Wong MCS, Wong SYS. Global burden, regional differences, trends and health consequences of medication non-adherence for hypertension during 2010 to 2020: A metaanalysis involving 27 million patients. J. Am. Heart Assoc ., 2022:11, e026582. doi: https://doi.org/10.1161/JAHA.122.026582
18. Ho MP, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS. Medication non-adherence is
associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J , 2008: 155(4): 772 - 779. doi: https://doi.org/10.1016/j.ahj.2007.12.011
19. Jayasree A, Shanmuganathan P, Ramamurthy P, Alwar MC. Types of Medication Non-adherence & Approaches to Enhance Medication Adherence in Mental Health Disorders: A Narrative Review. Indian J Psychol Med. 2024:46(6):503-510. doi: https://doi.org/10.1177/02537176241233745
20. Foley L, Larkin J, Lombard-Vance R, Morphy AW, Hynes L, Galvin E, Molloy GJ. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ open 2012: 11(9), e044987. doi:
https://doi.org/10.1136/bmjopen-2020-044987
21. Horne R, Chan A, Wileman V. Adherence to treatment, Handbook of health psychology. United Kingdom: Routledge, 2018:148-161.
22. Chapman SCE, Chan AHY. Medication nonadherence - definition, measurement, prevalence and causes: reflecting on the past 20 years and looking forwards. Front Pharmacol., 2025:16. doi : https://doi.org/10.3389/fphar.2025.1465059
23. Gong G, Dong A, Zhang Z, Mao J. Medication adherence and predictive factors among patients with rheumatoid arthritis: A COM-B model guided structural equation modeling analysis. Patient Educ Couns, 2024:119:108080. PMID: 37995488. doi:
https://doi.org/10.1016/j.pec.2023.108080
24. Ellis RJB, Ha ss e JE and Ruppa r TM. Understanding Processes, Outcomes and Contexts in Medication Adherence: The Medication Adherence Context and Outcomes (MACO) Framework. Patient Prefer Adherence 2023: 17: 239 - 248. doi:
https://doi.org/10.2147/PPA.S387813
25. Gil-Girbau M, Aznar-Lau I, Penarrubia-Maria MT, Moreno-Peral P, Fernandez A, Bellon JAet al. Reasons for medication non-initiation: A qualitative exploration of the patients' perspective. Res Social Adm Pharm, 2020: 16(5): 663 - 672. doi:
https://doi.org/10.1016/j.sapharm.2019.08.002
26. Koegh B, Murphy E, Doyle L, Sheaf G, Watts M, Higgins A. Mental health service users experiences of medication discontinuation: a systematic review of qualitative studies. J Ment H e a lt h , 2 0 1 2 : 3 1 ( 2 ) : 2 2 7 - 2 3 8 . d o i:
https://doi.org/10.1080/09638237.2021.1922644
27. World Health Organization (2003). Adherence to long-term therapies: evidence for action [Internet]. World Health Organization; 2003. [Accessed 2025 Oct 18]. Available from: https://apps.who.int/iris/handle/10665/42682
28. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LAet al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail, 2011:17(8):664-9. doi: https://doi.org/10.1016/j.cardfail.2011.04.011
29. Su M, Qin XS, Li Y, Upshur R, Sullivan F, Legare F et al. Association between medication adherence and cardiovascular outcomes in patients with both diabetes and hypertension in primary care settings in Canada: A retrospective cohort study. PLoS One, 2025:20(4):e0319991. d o i : https://doi.org/10.1371/journal.pone.0319991
30. Ho MP, Bryson CL, Rumsfeld JS. Medication Adherence: its importance in cardiovascular Outcomes. Circulation, 2009:119(23):3028-3 0 2 5 . d o i : https://doi.org/10.1161/CIRCULATIONAHA.108.768986
31. Zongo A, Simpson S, Johnson JA, Eurich DT. Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke or mortality: A cohort study. PLos One; 2019: 14(9): e0223062. doi: https://doi.org/10.1371/journal.pone.0223062
32. Kumar RS. Pharmacotherapy and the Critical Role of Pharmacists in Rehabilitation Medicine. Int J Innov Pharm Educ, 2024:1(1):45-46.
33. Marusic S, Gojo-Tomic N, Erdeljic V, Bacic-Vrca V, Franic M, Kirin M, Bozikov V. The effect of pharmacotherapeutic counselling on readmissions and emergency department visits. International Journal of Clinical Pharmacy, 2013: 35: 37 - 44. doi: https://doi.org/10.1007/s11096-012-9700-9
34. Viswanathan M, Kahwati LC, Golin CE. Medication Therapy Management Interventions In Outpatient Settings. JAMA Intern Med, 2015: 175(1): 76-87. d o i : https://doi.org/10.1001/jamainternmed.2014.5841
35. MacCallum L, Mathers A, Kellar J, RousseGrossman J, Moore J, Lewis GF, Dolovich L. Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: Asurvey of community pharmacists. Res Social Adm Pharm, 2020: 17(2). d o i: https://doi.org/10.1016/j.sapharm.2020.04.004
36. Faridi KF, Peterson ED, McCoy LA. Timing of First Postdischarge Follow-up and Medication Adherence After Myocardial Infarction. JAMA Cardiol, 2016: 1(2):147 - 155. Doi: https://doi.g/10.1001/jamacardio.2016.0001
37. Breault RR, Schindel TJ and Hughes CA. Pharmacist care planning services: what matters most. Can Pharm J, 2021:154(3):149–152. doi: https://doi.org/10.1177/17151635211004631
38. Andanalusia M, Nita Y and Athiyah U. The effect of pillbox use and education by pharmacists toward medication adherence in diabetes mellitus patients in a Primary Health Care Centre in Mataram. J Basic Clin Physiol Pharmacol, 2021: 32(4): 577 – 582. doi: https://doi.org/10.1515/jbcpp-2020-0500
39. Choi EPH. A pilot study to evaluate the acceptability of using a smart pillbox to enhance medication adherence among primary care patients. Int. J. Environ. Res. Public Health, 2019: 16(20) : 3964. doi : https://doi.org/10.3390/ijerph16203964
40. Fiorillo A, Barlati S, Bellomo A, Corrivetti G, Nicolò G, Sampogna G, Stanga V, Veltro F, Maina G, Vita A. The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: A clinical review. Ann. Gen. Psychiatry, 2 0 2 0 : 1 9 ( 4 3 ) . d o i : https://doi.org/10.1186/s12991-020-00293-4
41. Celio J, Ninane F, Bugnon O, Schneider MP. Pharmacists-nurse collaborations in medication adherence-enhancing interventions: A review. Patient Educ Couns, 2018:101(7); 1175–1192. doi: https://doi.org/10.1016/j.pec.2018.01.022
42. Baldoni S, Amenta F, Ricci G. Telepharmacy Services: Present Status and Future Perspectives: A Review. Medicina, 2019:55:327. doi: https://doi.org/10.3390/medicina55070327
43. Bruns BE, Lorenzo-Castro SA, Hale GM. Controlling Blood Pressure During a Pandemic: The Impact of Telepharmacy for Primary Care Patients. J Pharm Pract, 2022:37(2):364–368. doi: https://doi.org/10.1177/08971900221136629
44. Hursman A, Vang C, Thooft T, Stone K. The Role of Telepharmacy in the Delivery of Clinical Pharmacy Services Following the COVID-19 Pandemic: A Descriptive Report. J Pharm Technol, 2024: 40(2): 66 – 71. doi : https://doi.org/10.1177/87551225231222426
45. Conway CM, Kelechi TJ. Digital Health for Medication Adherence in Adult Diabetes or Hypertension: An Integrative Review. JMIR Diabetes, 2017: 2(2): e20. doi : https://doi.org/10.2196/diabetes.8030
46. Kang GC. Technology-based interventions to improve adherence to antihypertensive medications - An evidence-based review. Digit. Health 2022, 8, 20552076221089725. doi: https://doi.org/10.1177/20552076221089725
47. Peng Y, Wang H, Fang Q, Xie L, Shu L, Sun W, Liu Q. Effectiveness of mobile applications on medication adherence in adults with chronic diseases: A systematic review and meta-analysis. J. Manag. Care Spec. Pharm., 2020:26, 550–561. doi: https://doi.org/10.18553/jmcp.2020.26.4.550
48. Hood M, Wilson R, Corsica J, Bradley L, Chirinos D, Vivo A. What do we know about mobile applications for diabetes self-management? A review of reviews. J Behav Med, 2016: 39(6): 981 – 994. doi : https://doi.org/10.1007/s10865-016-9765-3
49. Patel N, Jones P, Adamson V, Spiteri M, Kinmond K. Chronic obstructive pulmonary disease patients' experiences of an enhanced selfmanagement model of care. Qual Health Res, 2016: 26(4): 568 – 577. doi: https://doi.org/10.1177/1049732315573013
50. Elnaem MH, Irwan NA, Abubakar U, Syed Sulaiman SA, Elrggal ME, Cheema E. Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions. Patient Prefer. Adherence, 2020: 14: 2135 – 2145. doi: https://doi.org/10.2147/ppa.s268499
51. Gonzalez-Bueno J, Sevilla-Sanchez D, PuigoriolJuvanteny E, Molist-Brunet N. Codina-Jane C, Espaulella-Panicot J. Factors Associated withMedication Non-Adherence among Patients with Multimorbidity and Polypharmacy Admitted to an Intermediate Care Center. Int J Environ Res Public Health, 2021:18(18):9606. doi: https://doi.org/10.3390/ijerph18189606
52. Oser CS, Fogle CC, Bennett JA. A Project to Promote Adherence to Blood Pressure Medication Among People Who Use Community Pharmacies in Rural Montana, 2014–2016. Prev Chronic Dis, 2017: 14: 160409. doi : http://dx.doi.org/10.5888/pcd14.160409
53. Okoro RN, Nduaguba SO. Community pharmacists on the frontline of chronic disease management: The need for primary healthcare policy reforms in low and middle income countries. Explor Res Clin Soc Pharm, 2021: 2, 100011. doi: https://doi.org/10.1016/j.rcsop.2021.100011
54. Kılıç H, Güneş ED. Patient adherence in healthcare operations: A narrative review. Soc Econ Plan Sci, 2024:91, 101795. doi:
Downloads
Views | PDF Downloads:
0
/ 0
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
